ClinicalTrials.gg
Active, not recruitingNCT06054412Updated Aug 19, 2026

An Adjunctive Neurofeedback Training Program to Enhance Wellness Among Trauma-Exposed Postpartum Mothers

An interventional study of Neuroptimal (Zengar, Inc.) Neurofeedback in Well-Being, Psychological, Dissociation and Maternal Care Patterns, sponsored by Wayne State University. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-08-19.

Primary conditionDissociative DisordersRegistry: Psychological Well-BeingReclassifiedWhy we changed it
Registry
Psychological Well-Being — the first condition term the registry derived for this study.
ClinicalTrials.gg
Dissociative Disorders
Why
  1. Psychological Well-Being is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Dissociative Disorders.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Wayne State University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The proposed study will collect novel data evaluating the feasibility of the NFB training program delivered in an outpatient mental health setting and its influence on mothers' overall sense of well-being, and further investigate whether enhanced well-being is associated with positive changes in emotion regulation capacities, trauma-related mental health symptoms, parenting behaviors and attitudes, and infant behavioral outcomes (i.e., crying, fussing) among postpartum mothers with a history of childhood trauma and clinically concerning trauma-related mental health symptoms.

02

Conditions studied

  • Well-Being, Psychological
  • Dissociation
  • Maternal Care Patterns
  • Maternal Behavior
  • Maternal Distress
  • Mood Disturbance
  • Emotional Regulation
  • Post Traumatic Stress Disorder
03

In context

Dissociative Disorders Reclassified

41 studies on the registry are indexed under Dissociative Disorders; 13 are open to participants now.

This study's planned enrollment of 20 is below the median of 50 across 34 interventional studies indexed under Dissociative Disorders.

Browse Dissociative Disorders studies →

Lead sponsor

Wayne State University is the lead sponsor of 230 studies on the registry; 35 are open to participants now.

Of its 17 completed or terminated interventional studies of FDA-regulated products, 4 (24%) have results posted.

Compared within Dissociative Disorders, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Psychological Well-Being. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Must have clinically concerning symptoms of Post-traumatic Stress Disorder and/or it's dissociative sub-type, as indicated by either a score of 3+ on the Primary Care PTSD Screen for (PC-PTSD-5) screening measure for PTSD symptoms OR endorsement of 2 or more past-month symptoms of moderate or greater severity on the depersonalization/derealization subscale of the Dissociative Subtype of PTSD Scale (DSPS).
  • Must be between 3-24 months postpartum
  • Must be receiving regular, primarily in-person psychotherapy from a therapist at a clinic in the Greater Detroit area.

Exclusion criteria

Exclusion Criteria:

  • Are currently pregnant
  • Have a lifetime history of significant untreated mental illness (not currently treated schizophrenia, schizoaffective disorder, bipolar disorder, or substance use disorder) or neurological or pervasive developmental disorder
  • Have a documented history of epilepsy
  • Have ever experienced previous head injury with loss of consciousness
  • Are currently experiencing domestic or intimate partner violence or otherwise state that their current living conditions are unsafe
  • Are currently experiencing psychosis or have been suicidal within the last six months
  • Are currently taking, or in the past month has taken benzodiazepines, narcotic drugs, or cannabis
  • Have engaged in self-harming behaviors in the last 3 months requiring medical attention
  • Do not have competence to understand or consent to the study procedures
  • Do not have fluency in written and spoken English
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Other
    Neurofeedback Training

    Mothers in the Neurofeedback Training group will complete pre and post-training self-report surveys assessing trauma symptoms, mental health, parenting attitudes and behaviors, and infant crying patterns and socioemotional development. Mothers in this group will all be receiving in-person psychotherapy outside of the study, and they will all demonstrate clinically significant symptoms aligned with post-traumatic stress disorder and/or it's dissociative subtype.

    Device: Neuroptimal (Zengar, Inc.) Neurofeedback

Interventions

  • DeviceNeuroptimal (Zengar, Inc.) Neurofeedback

    Mothers in the Neurofeedback Training group will complete one training session (lasting approximately 33 minutes) a week for a total of 12 weeks, using the Neuroptimal (Zengar, Inc.) neurofeedback device.

06

What researchers measure

Primary outcomes

  1. Neuro-QoL Item Bank v1.0 - Positive Affect and Well-Being - Short Form

    To measure maternal well-being. Minimum score = 9 Maximum score = 45 Higher scores mean a better outcome.

    Time frame: Weekly, throughout the course of the 3-month training phase

  2. Post-Traumatic Stress Disorder Checklist for the Diagnostic and Statistical Manual of Mental Disorders, Fith Edition (PTSD Checklist for DSM-5 - Standard)

    To measure maternal symptoms of PTSD Minimum score = 0 Maximum score = 80 Higher scores mean a worse outcome.

    Time frame: The measure will be administered at beginning of the study and again following the completion of the training phase, up to 4 months later.

  3. Dissociative Experiences Scale II

    To assess maternal symptoms of dissociation. Minimum score = 0 Maximum score = 100 Higher scores mean a worse outcome.

    Time frame: The measure will be administered at beginning of the study and again following the completion of the training phase, up to 4 months later.

  4. Patient Health Questionnaire 8

    To measure maternal depressive symptoms. Minimum score = 0 Maximum score = 24 Higher scores mean a worse outcome.

    Time frame: The measure will be administered at beginning of the study and again following the completion of the training phase, up to 4 months later.

  5. The State Trait Anger Expression Inventory

    To measure maternal anger control. Minimum score = 10 Maximum score = 40 Higher scores mean a worse outcome.

    Time frame: The measure will be administered at beginning of the study and again following the completion of the training phase, up to 4 months later.

  6. Brief Child Abuse Potential screener, an abbreviated version of the Child Abuse Potential Inventory ([CAP]), © 1980, 1986, Joel S. Milner, PhD.)

    The Brief Child Abuse Potential is a screening tool that is an abbreviated version of the Child Abuse Potential Inventory (\[CAP\]), © 1980, 1986, Joel S. Milner, PhD.). This measure is used to understand a caregiver's potential risk of perpetrating acts of child abuse. The measure includes 33 items; caregiver's endorse whether they "Agree" or "Disagree" with each item. Agree responses are given a score of 1, Disagree responses are given a score of 0. Minimum score = 0 Maximum score = 33 Higher scores mean a worse outcome.

    Time frame: The measure will be administered at beginning of the study and again following the completion of the training phase, up to 4 months later.

  7. Parenting Stress Index

    To measure stress associated with parenting. Minimum score = 36 Maximum score = 180 Higher scores mean a better outcome.

    Time frame: The measure will be administered at beginning of the study and again following the completion of the training phase, up to 4 months later.

  8. Parenting Sense of Competence scale

    To measure feelings of parental competency and self-efficacy. Minimum score = 0 Maximum score = 80 Higher scores mean a worse outcome.

    Time frame: The measure will be administered at beginning of the study and again following the completion of the training phase, up to 4 months later.

  9. The Crying Patterns Questionnaire

    To measure infant crying and fussing patterns. Minimum score = 0 Maximum score = 80 Higher scores mean a worse outcome.

    Time frame: The measure will be administered at beginning of the study and again following the completion of the training phase, up to 4 months later.

  10. The Baby Pediatric Symptom Checklist of the Survey of Well-Being for Young Children

    To measure infant psychosocial wellbeing. Minimum score = 0 Maximum score = 80 Higher scores mean a worse outcome.

    Time frame: The measure will be administered at beginning of the study and again following the completion of the training phase, up to 4 months later.

  11. Neuro-QoL Item Bank v1.0 - Emotional and Behavioral Dyscontrol - Short Form

    To measure maternal emotional and behavioral self-regulation. Minimum score = 0 Maximum score = 80 Higher scores mean a worse outcome.

    Time frame: Weekly, throughout the course of the 3-month intervention

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Mar 2024 to primary completion in Sep 2025, 17 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 13, 2023
First posted
Sep 26, 2023
StartActual
Mar 3, 2024
Primary completionActual
Sep 1, 2025
CompletionEst.
Dec 1, 2027
Last update
Aug 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06054412
Responsible party
Lisa S. Panisch, PhD, MSW (Assistant Professor, Wayne State University) — Principal investigator
First posted
Sep 26, 2023
Start date
Mar 3, 2024
Primary completion
Sep 1, 2025
Completion
Dec 1, 2027 (estimated)
Last update
Aug 19, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion